Last Updated: August 9, 2026

Litigation Details for AstraZeneca AB v. ScieGen Pharmaceuticals, Inc. (D. Del. 2024)

✉ Email this page to a colleague

« Back to Dashboard

AstraZeneca AB v. ScieGen Pharmaceuticals, Inc. (D. Del. 2024)

Docket	⤷ Start Trial	Date Filed	2024-08-08
Court	District Court, D. Delaware	Date Terminated	2025-06-10
Cause	35:1 Patent Infringement	Assigned To	Richard Gibson Andrews
Jury Demand	None	Referred To
Patents	7,851,502; 7,919,598; 8,221,786; 8,361,972; 8,501,698; 8,685,934; 8,716,251
Link to Docket	External link to docket

Small Molecule Drugs cited in AstraZeneca AB v. ScieGen Pharmaceuticals, Inc.

The small molecule drugs covered by the patents cited in this case are ⤷ Start Trial , ⤷ Start Trial , ⤷ Start Trial , ⤷ Start Trial , ⤷ Start Trial , and ⤷ Start Trial .

Details for AstraZeneca AB v. ScieGen Pharmaceuticals, Inc. (D. Del. 2024)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Date Filed	Document No.	Description	Snippet	Link To Document
2024-08-08				External link to document
2024-08-08	4	Patent/Trademark Report to Commissioner of Patents	Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,685,934; 7,851,502; 8,221,786; 8,361,972…8,716,251; 7,919,598 ; 8,501,698. (Attachments: # 1 Patent/Trademark Report)(mpb) (Entered: 08/08/2024) … 8 August 2024 1:24-cv-00923 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.